Laredo Arthritis & Rheumatology Center, PLLC

Laredo Arthritis & Rheumatology Center, PLLC was paid $1.39M by Medicaid between Jan 2018 and Nov 2024, across 23 billing codes. Its largest line is J0129, Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) — 95% of everything it billed.

Compared with peers

Next to other Rheumatology Physician providers in Texas

Rank by total paid#2 of 45

Median peer was paid$12K

This provider vs. median118×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	6,180	$204K
2019	5,724	$296K
2020	2,276	$251K
2021	2,693	$235K
2022	2,698	$203K
2023	2,158	$151K
2024incomplete	509	$51K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	95%	1,916	1,759	$1.32M
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	3.0%	4,691	4,509	$42K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	1.3%	1,864	1,735	$19K
20611		<1%	676	425	$4K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	<1%	512	508	$4K
99204	Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity	<1%	163	153	$2K
76881		<1%	153	74	$2K
J7321	Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose	<1%	54	25	$1K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	65	62	$193.52
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	323	91	$113.66
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	13	12	$67.64
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	141	37	$60.95

11 more codes

80076		<1%	2,534	$29.81
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	2,386	$27.78
82565		<1%	2,531	$23.70
73130		<1%	34	$21.90
86140		<1%	1,807	$13.67
71046	Radiologic examination, chest; 2 views	<1%	42	$10.07
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	263	$8.43
J7320	Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg	0%	90	$0.00
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	0%	77	$0.00
36415	Collection of venous blood by venipuncture	0%	1,890	$0.00
J1885	Injection, ketorolac tromethamine, per 15 mg	0%	13	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMANCERA, ANTONIO (PRESIDENT)